About the company
Biorce is a Barcelona-based healthtech company building an AI platform for clinical trials, focused on speeding up protocol creation, feasibility, and regulatory planning. The company markets the platform around explainability and compliance for regulated trial work. Biorce has raised reported funding rounds since late 2024 and has public backing from investors including Norrsken VC. Public product messaging positions the platform as used by clinical teams across multiple regions.